We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A Mouse Model of Amyloid β Oligomers: Their Contribution to Synaptic Alteration, Abnormal Tau Phosphorylation, Glial Activation, and Neuronal Loss In Vivo.
- Authors
Tomiyama, Takami; Matsuyama, Shogo; Iso, Hiroyuki; Umeda, Tomohiro; Takuma, Hiroshi; Ohnishi, Kiyouhisa; Ishibashi, Kenichi; Teraoka, Rie; Sakama, Naomi; Yamashita, Takenari; Nishitsuji, Kazuchika; Ito, Kazuhiro; Shimada, Hiroyuki; Lambert, Mary P.; Klein, William L.; Mori1, Hiroshi
- Abstract
Although amyloid β (Aβ) oligomers are presumed to cause synaptic and cognitive dysfunction in Alzheimer's disease (AD), their contribution to other pathological features of AD remains unclear. To address the latter, we generated APP transgenic mice expressing the E693Δ mutation, which causes AD by enhanced Aβ oligomerization without fibrillization. The mice displayed age-dependent accumulation of intraneuronal Aβ oligomers from 8 months but no extracellular amyloid deposits even at 24 months. Hippocampal synaptic plasticity and memory were impaired at 8 months, at which time the presynaptic marker synaptophysin began to decrease. Furthermore, we detected abnormal tau phosphorylation from 8 months, microglial activation from 12 months, astrocyte activation from 18 months, and neuronal loss at 24 months. These findings suggest that Aβ oligomers cause not only synaptic alteration but also other features of AD pathology and that these mice are a useful model of Aβ oligomer-induced pathology in the absence of amyloid plaques.
- Subjects
AMYLOID beta-protein precursor; OLIGOMERS; LABORATORY mice; NEURAL transmission; PHOSPHORYLATION; NEUROGLIA
- Publication
Journal of Neuroscience, 2010, Vol 30, Issue 14, p4845
- ISSN
0270-6474
- Publication type
Article
- DOI
10.1523/JNEUROSCI.5825-09.2010